(1S,7aS)-1-{[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl}-4-methylhexahydro-1H-pyrrolizinium, iodide

ID: ALA199866

Chembl Id: CHEMBL199866

PubChem CID: 11496399

Max Phase: Preclinical

Molecular Formula: C17H25ClIN3O2

Molecular Weight: 338.86

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CC[N@@+]2(C)CCC[C@@H]12.[I-]

Standard InChI:  InChI=1S/C17H24ClN3O2.HI/c1-21-6-3-4-15(21)11(5-7-21)10-20-17(22)12-8-13(18)14(19)9-16(12)23-2;/h8-9,11,15H,3-7,10H2,1-2H3,(H2-,19,20,22);1H/t11-,15-,21+;/m0./s1

Standard InChI Key:  MDLHHOYFXIQIGQ-LLOHZTEESA-N

Associated Targets(non-human)

HTR4 Serotonin 4 (5-HT4) receptor (2870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr4 Serotonin 4 (5-HT4) receptor (653 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr3b Serotonin 3 receptor (5HT3) (84 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 338.86Molecular Weight (Monoisotopic): 338.1630AlogP: 2.29#Rotatable Bonds: 4
Polar Surface Area: 64.35Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.58CX LogP: -2.95CX LogD: -2.95
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.65Np Likeness Score: 0.11

References

1. Becker DP, Flynn DL, Moormann AE, Nosal R, Villamil CI, Loeffler R, Gullikson GW, Moummi C, Yang DC..  (2006)  Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists.,  49  (3): [PMID:16451077] [10.1021/jm0509501]

Source